Page 24 - Pharming Group News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Equities Research Analysts’ new coverage for Wednesday, March 29th: StockNews.com began coverage on shares of ATA Creativity Global (NASDAQ:AACG). StockNews.com issued a sell rating on the stock. StockNews.com assumed coverage on shares of Atlantic American (NASDAQ:AAME). The firm issued a hold rating on the stock. StockNews.com began coverage on shares of Almaden Minerals (NYSEAMERICAN:AAU) (TSE:AMM). […]

Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock.

HC Wainwright reaffirmed their buy rating on shares of Pharming Group (NASDAQ:PHAR – Get Rating) in a research report report published on Monday morning, Benzinga reports. They currently have a $37.00 target price on the stock. Separately, TheStreet cut Pharming Group from a c rating to a d+ rating in a report on Wednesday, March […]

U.S. stocks traded higher this morning, with the Dow Jones gaining around 200 points on Monday. Following the market opening Monday, the Dow trad...

Pharming Group N.V. (PHAR) shares are sliding more than 19 percent on Monday morning trade after the stock plunged following a year-to-date high after receiving FDA approval for its immune disorder drug Leniolisib on March 24.